ArticleG3 (Bethesda, Md.)2026
Accurate genomic predictions for chronic wasting disease in North American elk.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The geographic expansion of chronic wasting disease (CWD) in North American elk (Cervus canadensis) has not been well mitigated by traditional best management practices, diagnostic surveillance, and depopulation of positive herds. Using a custom Affymetrix Axiom genetic variant array, we demonstrate that differential susceptibility to CWD is highly heritable (h2=0.630±0.061-0.678±0.056) among farmed North American elk, with loci other than PRNP involved. Genome-wide association analyses using 173,674 quality filtered variants for a geographically diverse cohort of 904 farmed North American elk (n = 357 CWD positive; n = 547 CWD nondetect) confirmed the prion gene (PRNP codon 132 Met→Leu and promoter variants) as a large-effect risk locus (P < 5.135E-08), as evidenced by the estimated proportion of phenotypic variance explained (PVE ≥ 0.032). However, more phenotypic variance was collectively explained by loci other than PRNP. Genomic best linear unbiased prediction (GBLUP; n = 173,674 markers) with k-fold cross-validation (k = 3; k = 5) and random sampling (n = 50 iterations) for the same cohort of 904 farmed North American elk produced mean genomic prediction accuracies ≥ 0.791, thereby providing a foundation to explore a genomically estimated CWD genetic improvement program.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.